Sofinnova Investments’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
2021
Q3
$10.1M Sell
2021
Q2
$12.7M Sell
2021
Q1
$23.6M Buy
2020
Q3
Sell
2020
Q2
$922K Buy
2020
Q1
Sell
2019
Q4
$14M Buy
2019
Q3
$2.4M Buy
2018
Q2
Sell
2018
Q1
$267K Buy